ALB and urinary bladder cancer: In an effort to improve the preoperative diagnosis of BC (without utilizing costly and limited available biomarkers), and considering the role of inflammation as a favorable factor in carcinogenesis, tumor progression, and metastasis, several systemic inflammatory markers have been investigated in relation to bladder cancer, comprising the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), and neutrophil percentage-to-albumin ratio (NPAR) [25,26,27,28].